Heather L. Van Epps, PhD

November 27, 2014

Despite the lack of data to justify them, periodic surveillance PET scans during remission are performed frequently.

November 26, 2014

For patients with B-cell lymphomas, new treatments are providing more options.

June 16, 2014

Researchers need to learn more about the biology of liver cancer to develop better treatments.

June 15, 2014

Refined treatments and targeted drugs signal slow yet significant progress for liver cancer.

March 08, 2014

One alternative to targeting specific tumor-associated proteins is to entice the patient’s immune system to attack the tumor directly.

March 06, 2014

Focusing on screening and genetic clues, progress in lung cancer shifts forward.

September 18, 2013

Understanding the molecular makeup of triple-negative breast cancer reveals new therapeutic targets.

June 19, 2013

With more knowledge, triple-negative breast cancer doesn't seem so scary.

June 18, 2013

New treatments for multiple myeloma target the disease in different ways.

March 14, 2013

Sarcoma is more common in children and young adults.

March 13, 2013

Soft tissue sarcoma has benefited from research in other cancers.

September 14, 2012

Patients whose breast cancers are estrogen-positive have a wide variety of treatments available.

September 14, 2012

Neoadjuvant breast cancer therapy may be beneficial.

June 15, 2012

Some drugs used to treat cancer can trigger physiological responses that manifest in feelings of anger.

June 10, 2012

Coping with anger during cancer can be difficult.

March 14, 2012

New treatments for bladder cancer may be nearing the finish line.

March 14, 2012

Advocating for yourself.

December 21, 2011

The latest advancements in the treatment of Hodgkin lymphoma.

December 21, 2011

Although called a "good" cancer, Hodgkin lymphoma isn't always curable.

March 13, 2009

Half of adult patients diagnosed with non-Hodgkin lymphoma are over age 60--oncologists must take into account age and associated complications.

December 09, 2008

Predicting drug response in colorectal cancer.

December 09, 2008

KRAS gene mutations are detected in various cancers, including colorectal.

December 09, 2008

Issues after surgery can be taxing for patient and caregiver.

June 11, 2007

Exposing the ethical dilemmas of clinical trials reveals a balance between researchers, drug companies, and patients.

June 11, 2007

Data collection doesn’t end when a clinical trial ends, as rare or long-term side effects of a new drug or treatment may take years to emerge.

December 19, 2006

In an aging population, cancer is rarely a solo act.